APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disposable Hemoperfusion

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.

Selected research

Market Outlook & Growth Opportunities

Global Disposable Hemoperfusion Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchDisposable Hemoperfusion Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Disposable Hemoperfusion Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Disposable Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disposable Hemoperfusion Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Disposable Hemoperfusion Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.

China is the largest market with about 48% market share. Followed by Europe and Japan, accounting for about 35% market share.

The key players are Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical etc. Top 3 companies occupied about 64% revenue market share.

Read the full market overview

This report provides an overview of the global Disposable Hemoperfusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Disposable Hemoperfusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Disposable Hemoperfusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Disposable Hemoperfusion market size, projected growth trends, production technologies, key applications, and end-use industries.

Disposable Hemoperfusion Segment by Company

Baxter International

Asahi Kasei Corporation

CytoSorbentsCompany 11

Kaneka Pharma

Toray Medical

Aier

Tianjin Zibo High Technology

Biosun Corporation

Kangbei Medical Device

Jafron Biomedical

Disposable Hemoperfusion Segment by Type

Charcoal Hemoperfusion

Certain Resins Hemoperfusion

Disposable Hemoperfusion Segment by Application

Overdose

Specific Intoxications

Certain Autoimmune Diseases

Hepatic Encephalopathy

Others

Disposable Hemoperfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Disposable Hemoperfusion status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Disposable Hemoperfusion market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Disposable Hemoperfusion significant trends, drivers, influence factors in global and regions.

6. To analyze Disposable Hemoperfusion competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disposable Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disposable Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disposable Hemoperfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Disposable Hemoperfusion market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Disposable Hemoperfusion industry.

Chapter 3: Detailed analysis of Disposable Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Disposable Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Disposable Hemoperfusion in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Disposable Hemoperfusion Industry Trends Table 2. Disposable Hemoperfusion Industry Drivers Table 3. Disposable Hemoperfusion Industry Opportunities and Challenges Table 4. Disposable Hemoperfusion Industry Restraints Table 5. Global Disposable Hemoperfusion Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Disposable Hemoperfusion Revenue Share by Company (2021-2026) Table 7. Global Disposable Hemoperfusion Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Disposable Hemoperfusion Sales Volume Share by Company (2021-2026) Table 9. Global Disposable Hemoperfusion Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Disposable Hemoperfusion Company Ranking, (2024-2026) & (USD Million) Table 11. Global Disposable Hemoperfusion Key Company Manufacturing Base & Headquarters Table 12. Global Disposable Hemoperfusion Company, Product Type & Application Table 13. Global Disposable Hemoperfusion Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Disposable Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Charcoal Hemoperfusion Table 18. Significant Companies of Certain Resins Hemoperfusion Table 19. Global Disposable Hemoperfusion Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Disposable Hemoperfusion Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Disposable Hemoperfusion Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Disposable Hemoperfusion Sales Volume Share by Type (2021-2026) Table 23. Global Disposable Hemoperfusion Sales Volume Share by Type (2027-2032) Table 24. Global Disposable Hemoperfusion Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Disposable Hemoperfusion Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Disposable Hemoperfusion Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Disposable Hemoperfusion Sales Value Share by Type (2021-2026) Table 28. Global Disposable Hemoperfusion Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Overdose Table 30. Significant Companies of Specific Intoxications Table 31. Significant Companies of Certain Autoimmune Diseases Table 32. Significant Companies of Hepatic Encephalopathy Table 33. Significant Companies of Others Table 34. Global Disposable Hemoperfusion Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Disposable Hemoperfusion Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Disposable Hemoperfusion Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Disposable Hemoperfusion Sales Volume Share by Application (2021-2026) Table 38. Global Disposable Hemoperfusion Sales Volume Share by Application (2027-2032) Table 39. Global Disposable Hemoperfusion Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Disposable Hemoperfusion Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Disposable Hemoperfusion Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Disposable Hemoperfusion Sales Value Share by Application (2021-2026) Table 43. Global Disposable Hemoperfusion Sales Value Share by Application (2027-2032) Table 44. Global Disposable Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Disposable Hemoperfusion Sales by Region (2021-2026) & (K Units) Table 46. Global Disposable Hemoperfusion Sales Market Share by Region (2021-2026) Table 47. Global Disposable Hemoperfusion Sales by Region (2027-2032) & (K Units) Table 48. Global Disposable Hemoperfusion Sales Market Share by Region (2027-2032) Table 49. Global Disposable Hemoperfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Disposable Hemoperfusion Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Disposable Hemoperfusion Sales Value Share by Region (2021-2026) Table 52. Global Disposable Hemoperfusion Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Disposable Hemoperfusion Sales Value Share by Region (2027-2032) Table 54. Global Disposable Hemoperfusion Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Disposable Hemoperfusion Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Disposable Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Disposable Hemoperfusion Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Disposable Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 59. Global Disposable Hemoperfusion Sales Market Share by Country (2021-2026) Table 60. Global Disposable Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 61. Global Disposable Hemoperfusion Sales Market Share by Country (2027-2032) Table 62. Global Disposable Hemoperfusion Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Disposable Hemoperfusion Sales Value Market Share by Country (2021-2026) Table 64. Global Disposable Hemoperfusion Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Disposable Hemoperfusion Sales Value Market Share by Country (2027-2032) Table 66. Baxter International Company Information Table 67. Baxter International Business Overview Table 68. Baxter International Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Baxter International Disposable Hemoperfusion Product Portfolio Table 70. Baxter International Recent Development Table 71. Asahi Kasei Corporation Company Information Table 72. Asahi Kasei Corporation Business Overview Table 73. Asahi Kasei Corporation Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Asahi Kasei Corporation Disposable Hemoperfusion Product Portfolio Table 75. Asahi Kasei Corporation Recent Development Table 76. CytoSorbentsCompany 11 Company Information Table 77. CytoSorbentsCompany 11 Business Overview Table 78. CytoSorbentsCompany 11 Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. CytoSorbentsCompany 11 Disposable Hemoperfusion Product Portfolio Table 80. CytoSorbentsCompany 11 Recent Development Table 81. Kaneka Pharma Company Information Table 82. Kaneka Pharma Business Overview Table 83. Kaneka Pharma Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Kaneka Pharma Disposable Hemoperfusion Product Portfolio Table 85. Kaneka Pharma Recent Development Table 86. Toray Medical Company Information Table 87. Toray Medical Business Overview Table 88. Toray Medical Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Toray Medical Disposable Hemoperfusion Product Portfolio Table 90. Toray Medical Recent Development Table 91. Aier Company Information Table 92. Aier Business Overview Table 93. Aier Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Aier Disposable Hemoperfusion Product Portfolio Table 95. Aier Recent Development Table 96. Tianjin Zibo High Technology Company Information Table 97. Tianjin Zibo High Technology Business Overview Table 98. Tianjin Zibo High Technology Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Tianjin Zibo High Technology Disposable Hemoperfusion Product Portfolio Table 100. Tianjin Zibo High Technology Recent Development Table 101. Biosun Corporation Company Information Table 102. Biosun Corporation Business Overview Table 103. Biosun Corporation Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Biosun Corporation Disposable Hemoperfusion Product Portfolio Table 105. Biosun Corporation Recent Development Table 106. Kangbei Medical Device Company Information Table 107. Kangbei Medical Device Business Overview Table 108. Kangbei Medical Device Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Kangbei Medical Device Disposable Hemoperfusion Product Portfolio Table 110. Kangbei Medical Device Recent Development Table 111. Jafron Biomedical Company Information Table 112. Jafron Biomedical Business Overview Table 113. Jafron Biomedical Disposable Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Jafron Biomedical Disposable Hemoperfusion Product Portfolio Table 115. Jafron Biomedical Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Disposable Hemoperfusion Distributors List Table 119. Disposable Hemoperfusion Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Disposable Hemoperfusion Product Image Figure 2. Global Disposable Hemoperfusion Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 4. Global Disposable Hemoperfusion Sales (2021-2032) & (K Units) Figure 5. Global Disposable Hemoperfusion Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Disposable Hemoperfusion Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Charcoal Hemoperfusion Image Figure 10. Certain Resins Hemoperfusion Image Figure 11. Global Disposable Hemoperfusion Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Disposable Hemoperfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Disposable Hemoperfusion Sales Volume Share by Type (2021-2032) Figure 14. Global Disposable Hemoperfusion Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Disposable Hemoperfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Disposable Hemoperfusion Sales Value Share by Type (2021-2032) Figure 17. Overdose Image Figure 18. Specific Intoxications Image Figure 19. Certain Autoimmune Diseases Image Figure 20. Hepatic Encephalopathy Image Figure 21. Others Image Figure 22. Global Disposable Hemoperfusion Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Disposable Hemoperfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Disposable Hemoperfusion Sales Volume Share by Application (2021-2032) Figure 25. Global Disposable Hemoperfusion Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Disposable Hemoperfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Disposable Hemoperfusion Sales Value Share by Application (2021-2032) Figure 28. Global Disposable Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Disposable Hemoperfusion Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Disposable Hemoperfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Disposable Hemoperfusion Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 33. North America Disposable Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Disposable Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Disposable Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 39. South America Disposable Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Disposable Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Disposable Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Disposable Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Disposable Hemoperfusion Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Disposable Hemoperfusion Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Charcoal Hemoperfusion
  • Certain Resins Hemoperfusion
Applications
  • Overdose
  • Specific Intoxications
  • Certain Autoimmune Diseases
  • Hepatic Encephalopathy
  • Others
Companies covered
  • Baxter International
  • Asahi Kasei Corporation
  • CytoSorbentsCompany 11
  • Kaneka Pharma
  • Toray Medical
  • Aier
  • Tianjin Zibo High Technology
  • Biosun Corporation
  • Kangbei Medical Device
  • Jafron Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Disposable Hemoperfusion Sales Value (2021-2032)
  4. 1.2.2 Global Disposable Hemoperfusion Sales Volume (2021-2032)
  5. 1.2.3 Global Disposable Hemoperfusion Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Disposable Hemoperfusion Market Dynamics
  1. 2.1 Disposable Hemoperfusion Industry Trends
  2. 2.2 Disposable Hemoperfusion Industry Drivers
  3. 2.3 Disposable Hemoperfusion Industry Opportunities and Challenges
  4. 2.4 Disposable Hemoperfusion Industry Restraints
3 Disposable Hemoperfusion Market by Company
  1. 3.1 Global Disposable Hemoperfusion Company Revenue Ranking in 2025
  2. 3.2 Global Disposable Hemoperfusion Revenue by Company (2021-2026)
  3. 3.3 Global Disposable Hemoperfusion Sales Volume by Company (2021-2026)
  4. 3.4 Global Disposable Hemoperfusion Average Price by Company (2021-2026)
  5. 3.5 Global Disposable Hemoperfusion Company Ranking (2024-2026)
  6. 3.6 Global Disposable Hemoperfusion Company Manufacturing Base and Headquarters
  7. 3.7 Global Disposable Hemoperfusion Company Product Type and Application
  8. 3.8 Global Disposable Hemoperfusion Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Disposable Hemoperfusion Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Disposable Hemoperfusion Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Disposable Hemoperfusion Market by Type
  1. 4.1 Disposable Hemoperfusion Type Introduction
  2. 4.1.1 Charcoal Hemoperfusion
  3. 4.1.2 Certain Resins Hemoperfusion
  4. 4.2 Global Disposable Hemoperfusion Sales Volume by Type
  5. 4.2.1 Global Disposable Hemoperfusion Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Disposable Hemoperfusion Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Disposable Hemoperfusion Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Disposable Hemoperfusion Sales Value by Type
  9. 4.3.1 Global Disposable Hemoperfusion Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Disposable Hemoperfusion Sales Value by Type (2021-2032)
  11. 4.3.3 Global Disposable Hemoperfusion Sales Value Share by Type (2021-2032)
5 Disposable Hemoperfusion Market by Application
  1. 5.1 Disposable Hemoperfusion Application Introduction
  2. 5.1.1 Overdose
  3. 5.1.2 Specific Intoxications
  4. 5.1.3 Certain Autoimmune Diseases
  5. 5.1.4 Hepatic Encephalopathy
  6. 5.1.5 Others
  7. 5.2 Global Disposable Hemoperfusion Sales Volume by Application
  8. 5.2.1 Global Disposable Hemoperfusion Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Disposable Hemoperfusion Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Disposable Hemoperfusion Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Disposable Hemoperfusion Sales Value by Application
  12. 5.3.1 Global Disposable Hemoperfusion Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Disposable Hemoperfusion Sales Value by Application (2021-2032)
  14. 5.3.3 Global Disposable Hemoperfusion Sales Value Share by Application (2021-2032)
6 Disposable Hemoperfusion Regional Sales and Value Analysis
  1. 6.1 Global Disposable Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Disposable Hemoperfusion Sales by Region (2021-2032)
  3. 6.2.1 Global Disposable Hemoperfusion Sales by Region: 2021-2026
  4. 6.2.2 Global Disposable Hemoperfusion Sales by Region (2027-2032)
  5. 6.3 Global Disposable Hemoperfusion Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Disposable Hemoperfusion Sales Value by Region (2021-2032)
  7. 6.4.1 Global Disposable Hemoperfusion Sales Value by Region: 2021-2026
  8. 6.4.2 Global Disposable Hemoperfusion Sales Value by Region (2027-2032)
  9. 6.5 Global Disposable Hemoperfusion Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Disposable Hemoperfusion Sales Value (2021-2032)
  12. 6.6.2 North America Disposable Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Disposable Hemoperfusion Sales Value (2021-2032)
  15. 6.7.2 Europe Disposable Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Disposable Hemoperfusion Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Disposable Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Disposable Hemoperfusion Sales Value (2021-2032)
  21. 6.9.2 South America Disposable Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Disposable Hemoperfusion Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Disposable Hemoperfusion Sales Value Share by Country, 2025 VS 2032
7 Disposable Hemoperfusion Country-level Sales and Value Analysis
  1. 7.1 Global Disposable Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Disposable Hemoperfusion Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Disposable Hemoperfusion Sales by Country (2021-2032)
  4. 7.3.1 Global Disposable Hemoperfusion Sales by Country (2021-2026)
  5. 7.3.2 Global Disposable Hemoperfusion Sales by Country (2027-2032)
  6. 7.4 Global Disposable Hemoperfusion Sales Value by Country (2021-2032)
  7. 7.4.1 Global Disposable Hemoperfusion Sales Value by Country (2021-2026)
  8. 7.4.2 Global Disposable Hemoperfusion Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Disposable Hemoperfusion Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Disposable Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Disposable Hemoperfusion Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter International
  2. 8.1.1 Baxter International Company Information
  3. 8.1.2 Baxter International Business Overview
  4. 8.1.3 Baxter International Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baxter International Disposable Hemoperfusion Product Portfolio
  6. 8.1.5 Baxter International Recent Developments
  7. 8.2 Asahi Kasei Corporation
  8. 8.2.1 Asahi Kasei Corporation Company Information
  9. 8.2.2 Asahi Kasei Corporation Business Overview
  10. 8.2.3 Asahi Kasei Corporation Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Asahi Kasei Corporation Disposable Hemoperfusion Product Portfolio
  12. 8.2.5 Asahi Kasei Corporation Recent Developments
  13. 8.3 CytoSorbentsCompany 11
  14. 8.3.1 CytoSorbentsCompany 11 Company Information
  15. 8.3.2 CytoSorbentsCompany 11 Business Overview
  16. 8.3.3 CytoSorbentsCompany 11 Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CytoSorbentsCompany 11 Disposable Hemoperfusion Product Portfolio
  18. 8.3.5 CytoSorbentsCompany 11 Recent Developments
  19. 8.4 Kaneka Pharma
  20. 8.4.1 Kaneka Pharma Company Information
  21. 8.4.2 Kaneka Pharma Business Overview
  22. 8.4.3 Kaneka Pharma Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kaneka Pharma Disposable Hemoperfusion Product Portfolio
  24. 8.4.5 Kaneka Pharma Recent Developments
  25. 8.5 Toray Medical
  26. 8.5.1 Toray Medical Company Information
  27. 8.5.2 Toray Medical Business Overview
  28. 8.5.3 Toray Medical Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Toray Medical Disposable Hemoperfusion Product Portfolio
  30. 8.5.5 Toray Medical Recent Developments
  31. 8.6 Aier
  32. 8.6.1 Aier Company Information
  33. 8.6.2 Aier Business Overview
  34. 8.6.3 Aier Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aier Disposable Hemoperfusion Product Portfolio
  36. 8.6.5 Aier Recent Developments
  37. 8.7 Tianjin Zibo High Technology
  38. 8.7.1 Tianjin Zibo High Technology Company Information
  39. 8.7.2 Tianjin Zibo High Technology Business Overview
  40. 8.7.3 Tianjin Zibo High Technology Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tianjin Zibo High Technology Disposable Hemoperfusion Product Portfolio
  42. 8.7.5 Tianjin Zibo High Technology Recent Developments
  43. 8.8 Biosun Corporation
  44. 8.8.1 Biosun Corporation Company Information
  45. 8.8.2 Biosun Corporation Business Overview
  46. 8.8.3 Biosun Corporation Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biosun Corporation Disposable Hemoperfusion Product Portfolio
  48. 8.8.5 Biosun Corporation Recent Developments
  49. 8.9 Kangbei Medical Device
  50. 8.9.1 Kangbei Medical Device Company Information
  51. 8.9.2 Kangbei Medical Device Business Overview
  52. 8.9.3 Kangbei Medical Device Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Kangbei Medical Device Disposable Hemoperfusion Product Portfolio
  54. 8.9.5 Kangbei Medical Device Recent Developments
  55. 8.10 Jafron Biomedical
  56. 8.10.1 Jafron Biomedical Company Information
  57. 8.10.2 Jafron Biomedical Business Overview
  58. 8.10.3 Jafron Biomedical Disposable Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jafron Biomedical Disposable Hemoperfusion Product Portfolio
  60. 8.10.5 Jafron Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Disposable Hemoperfusion Value Chain Analysis
  2. 9.1.1 Disposable Hemoperfusion Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Disposable Hemoperfusion Sales Mode & Process
  6. 9.2 Disposable Hemoperfusion Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Disposable Hemoperfusion Distributors
  9. 9.2.3 Disposable Hemoperfusion Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst